---
title: "小鵬汽車： 2025 年 9 月，小鵬汽車出口量突破 5000 台，環比增長 65.8%，同比增長 79.4%。 2025 年 1-9 月，小鵬汽車出口量超 29,723 輛，同比增長 125.2%。"
description: "小鵬汽車： 2025 年 9 月，小鵬汽車出口量突破 5000 台，環比增長 65.8%，同比增長 79.4%。 2025 年 1-9 月，小鵬汽車出口量超 29,723 輛，同比增長 125.2%。"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/261359956.md"
published_at: "2025-10-16T03:31:30.000Z"
---

# 小鵬汽車： 2025 年 9 月，小鵬汽車出口量突破 5000 台，環比增長 65.8%，同比增長 79.4%。 2025 年 1-9 月，小鵬汽車出口量超 29,723 輛，同比增長 125.2%。

小鵬汽車： 2025 年 9 月，小鵬汽車出口量突破 5000 台，環比增長 65.8%，同比增長 79.4%。 2025 年 1-9 月，小鵬汽車出口量超 29,723 輛，同比增長 125.2%。

### Related Stocks

- [XPEV.US - 小鵬汽車](https://longbridge.com/zh-HK/quote/XPEV.US.md)
- [09868.HK - 小鵬汽車-W](https://longbridge.com/zh-HK/quote/09868.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Xpeng secures L3 autonomous driving road test permits in Guangzhou | Xpeng has secured L3 autonomous driving road test permits in Guangzhou, marking a significant regulatory update in China | [Link](https://longbridge.com/zh-HK/news/269821815.md) |
| XPEV Earnings: XPeng Stock Falls Despite Narrower Q3 Loss and Solid Margins. Here's Why | XPeng (XPEV) reported a narrower Q3 loss and improved margins, with revenue up 101.8% year-over-year. Despite this, XPEV | [Link](https://longbridge.com/zh-HK/news/266175267.md) |
| ROI-West needs its own pricing to escape China's rare earths grip: Andy Home | A recent surge in rare earth prices has lifted them above the U.S. government's guaranteed floor price for MP Materials, | [Link](https://longbridge.com/zh-HK/news/276459435.md) |
| Xpeng reveals GX as new flagship SUV | Xpeng, a Chinese EV maker, is set to launch its new flagship six-seater SUV, the GX, in China. The model will be availab | [Link](https://longbridge.com/zh-HK/news/276145922.md) |
| Toyota’s best-selling car in Europe is going EV | Toyota is set to launch the Yaris as an electric vehicle (EV), following the electrification of the Corolla. CEO Koji Sa | [Link](https://longbridge.com/zh-HK/news/276141173.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。